Kerecis Revenue and Competitors

Isafjordur, USA

Location

#1497

Growjo Ranking

Estimated Revenue & Valuation

  • Kerecis's estimated annual revenue is currently $237.2M per year.(i)
  • Kerecis's estimated revenue per employee is $351,400
  • Kerecis's total funding is $93M.

Employee Data

  • Kerecis has 675 Employees.(i)
  • Kerecis grew their employee count by 63% last year.

Kerecis's People

NameTitleEmail/Phone
1
Founder, Chairman & PresidentReveal Email/Phone
2
VP Medical Collaboration and EngagementReveal Email/Phone
3
SVP for Research & DevelopmentReveal Email/Phone
4
VP Surgical & Burn SalesReveal Email/Phone
5
Director Sales - MidSouthReveal Email/Phone
6
Regional DirectorReveal Email/Phone
7
Sales Operation DirectorReveal Email/Phone
8
US Finance Operations DirectorReveal Email/Phone
9
Director Field ReimbursementReveal Email/Phone
10
Director Field ReimbursementReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M40-18%$10MN/A
#2
$24.8M9929%N/AN/A
#3
$84.1M0N/A$1.2MN/A
#4
$35.6M14230%N/AN/A
#5
$57.5M2296%N/AN/A
#6
$52.7M16825%$129.6MN/A
#7
$21.1M84-3%N/AN/A
#8
$61.2M244-13%N/AN/A
#9
$60.6M19320%$115.5MN/A
#10
$56.2M179-3%$122.9MN/A
Add Company

What Is Kerecis?

Kerecis has developed the unique, patented Kerecisâ„¢ Omega3 fish-skin transplantation technology, where intact fish skin is used for tissue regeneration. The Kerecisâ„¢ Omega3 transplantation technology is used to reconstruct tissue damage such as burn and diabetic wounds as well as for oral wounds, hernia repair, breast reconstruction and for dura restoration. Other tissue-transplant products are based on tissues of human and porcine origin. The Kerecisâ„¢ Omega3 fish skin offers improved economics and clinical performance, as well as reduced disease transfer risk and no cultural constraints on usage. Kerecis' second technology platform is the patented mOmega3 polyunsaturated fatty acid technology, where fatty acids are extracted from fish skin and incorporated in patented dermatological skin treatment products.

keywords:Biotechnology, Medical Devices

$93M

Total Funding

675

Number of Employees

$237.2M

Revenue (est)

63%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Kerecis News

2022-04-06 - Medical Fish-Skin Company Kerecis Introduces MariGen ...

MariGen™ Expanse, the newest addition to Kerecis' product offerings, supports healing and tissue regeneration in large chronic wounds. Tweet...

2022-03-30 - Medical-Fish-Skin Company Kerecis and Arctic Circle Partner ...

Specifically, the partnership will enable Kerecis to participate in Arctic Circle's discussions, assemblies and forums where issues, proposals...

2022-03-30 - Kerecis Medical Fish Skin to Be Available for Healogics ...

This makes Kerecis medical-fish-skin products available to Healogics Wound Care Centers®, expanding the options to treat chronic, non-healing...

2020-08-27 - Kerecis Raises $21M Financing

ARLINGTON, Va. & REYKJAVIK, Iceland--(BUSINESS WIRE)--Kerecis Limited, a regenerative-medicine biologics company, has secured $21 million in new financing. Silicon Valley Bank is providing a revolving line of credit of up to $15 million to meet the company’s near-term working-capital needs. Als ...

2020-08-27 - Kerecis Secures USD$21M Financing

Kerecis Limited, an Arlington, Va.- and Reykjavik, Iceland-based regenerative-medicine biologics company, secured $21m in financing. Silicon Valley Bank is providing a revolving line of credit of up to $15 million to meet the company’s near-term working-capital needs. The facility is an asset-b ...